Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a

K A Espy1, I M Moore, P M Kaufmann

  • 1Department of Psychiatry, Southern Illinois University, Carbondale, IL 62901-6503, USA. kespy@siumed.edu

Insights

Prophylactic central nervous system (CNS) chemotherapy for childhood acute lymphoblastic leukemia may lead to modest declines in arithmetic, visual motor integration, and verbal fluency. Treatment type and demographic factors influence these long-term neurocognitive outcomes.

Area of Science:

  • Pediatric Oncology
  • Neuropsychology
  • Childhood Cancer Survivorship

Background:

  • Childhood acute lymphoblastic leukemia (ALL) treatment often involves central nervous system (CNS) prophylaxis.
  • The long-term neurocognitive effects of these treatments require thorough investigation.

Purpose of the Study:

  • To assess the association between CNS chemotherapy for childhood ALL and subsequent neuropsychological abilities.
  • To identify factors influencing neurocognitive outcomes and changes over time.

Main Methods:

  • Longitudinal study using growth curve analysis in 30 children treated for ALL.
  • Comprehensive neuropsychological testing at baseline and at 2, 3, and 4 years postdiagnosis.

Main Results:

  • Modest declines observed in arithmetic, visual motor integration, and verbal fluency.
  • Combined intrathecal and systemic treatment correlated with poorer visual motor integration and faster skill decline compared to intrathecal treatment alone.
  • Maternal education influenced arithmetic proficiency, but not its rate of decline.

Conclusions:

  • Neuropsychological outcomes and decline rates in childhood ALL survivors are influenced by a combination of demographic factors and treatment characteristics.
  • Cognitive domain-specific effects highlight the need for personalized follow-up care.
Abstract

Related Concept Videos